PROCEPT BioRobotics Corporation
NASDAQ:PRCT
96.23 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 58.37 | 53.353 | 44.539 | 43.581 | 35.102 | 33.104 | 24.404 | 23.777 | 20.349 | 16.691 | 14.197 | 10.138 | 8.668 | 8.476 | 7.192 | 3.221 | 2.107 | 1.195 | 1.195 |
| Cost of Revenue
| 21.459 | 23.14 | 19.505 | 23.644 | 16.228 | 14.675 | 11.913 | 13.101 | 10.118 | 8.205 | 6.505 | 5.622 | 4.428 | 4.893 | 3.665 | 2.751 | 2.138 | 2.041 | 2.041 |
| Gross Profit
| 36.911 | 30.213 | 25.034 | 19.937 | 18.874 | 18.429 | 12.491 | 10.676 | 10.231 | 8.486 | 7.692 | 4.516 | 4.24 | 3.583 | 3.527 | 0.47 | -0.031 | -0.847 | -0.847 |
| Gross Profit Ratio
| 0.632 | 0.566 | 0.562 | 0.457 | 0.538 | 0.557 | 0.512 | 0.449 | 0.503 | 0.508 | 0.542 | 0.445 | 0.489 | 0.423 | 0.49 | 0.146 | -0.015 | -0.709 | -0.709 |
| Reseach & Development Expenses
| 16.647 | 16.232 | 13.084 | 13.178 | 11.6 | 11.613 | 10.737 | 9.682 | 7.582 | 6.706 | 5.011 | 5.076 | 4.919 | 4.476 | 4.522 | 4.543 | 3.893 | 3.92 | 3.92 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 42.691 | 40.809 | 39.599 | 36.316 | 32.883 | 32.441 | 30.131 | 26.034 | 24.754 | 19.655 | 18.385 | 16.271 | 12.118 | 12.299 | 10.349 | 9.134 | 7.054 | 7.042 | 7.042 |
| Other Expenses
| 1.328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.059 | -0.067 | -0.052 | -0.027 | -0.009 | -0.016 | 0.018 | 0 | 0 |
| Operating Expenses
| 59.338 | 57.041 | 52.683 | 49.494 | 44.483 | 44.054 | 40.868 | 35.716 | 32.336 | 26.361 | 23.396 | 21.347 | 17.037 | 16.775 | 14.871 | 13.677 | 10.947 | 11.037 | 11.037 |
| Operating Income
| -22.427 | -26.828 | -27.649 | -29.557 | -25.609 | -25.625 | -28.377 | -25.04 | -22.105 | -17.875 | -15.704 | -16.831 | -12.797 | -13.192 | -11.344 | -13.207 | -10.978 | -11.808 | -11.808 |
| Operating Income Ratio
| -0.384 | -0.503 | -0.621 | -0.678 | -0.73 | -0.774 | -1.163 | -1.053 | -1.086 | -1.071 | -1.106 | -1.66 | -1.476 | -1.556 | -1.577 | -4.1 | -5.21 | -9.885 | -9.885 |
| Total Other Income Expenses Net
| 1.453 | 1.202 | 1.692 | 2.053 | 0.987 | 0.34 | -0.107 | -3.132 | -0.508 | -1.309 | -1.481 | -0.104 | 0.141 | 0.035 | -0.028 | -0.323 | 0.334 | -1.058 | -1.058 |
| Income Before Tax
| -20.974 | -25.626 | -25.957 | -27.504 | -24.622 | -25.285 | -28.484 | -28.172 | -22.613 | -19.184 | -17.185 | -18.348 | -14.103 | -14.58 | -12.822 | -15.278 | -12.008 | -12.866 | -12.866 |
| Income Before Tax Ratio
| -0.359 | -0.48 | -0.583 | -0.631 | -0.701 | -0.764 | -1.167 | -1.185 | -1.111 | -1.149 | -1.21 | -1.81 | -1.627 | -1.72 | -1.783 | -4.743 | -5.699 | -10.771 | -10.771 |
| Income Tax Expense
| -1.328 | 0 | 1.141 | 1.833 | -1.054 | 1.183 | -0.779 | 3.132 | 0.508 | 1.309 | 1.481 | -8.666 | 0.814 | 1.471 | 1.455 | 1.755 | 1.405 | 0 | 0 |
| Net Income
| -20.974 | -25.626 | -25.957 | -27.504 | -24.622 | -25.285 | -27.705 | -31.304 | -23.121 | -20.493 | -18.666 | -18.348 | -14.103 | -14.58 | -12.822 | -15.278 | -12.008 | -12.866 | -12.866 |
| Net Income Ratio
| -0.359 | -0.48 | -0.583 | -0.631 | -0.701 | -0.764 | -1.135 | -1.317 | -1.136 | -1.228 | -1.315 | -1.81 | -1.627 | -1.72 | -1.783 | -4.743 | -5.699 | -10.771 | -10.771 |
| EPS
| -0.4 | -0.5 | -0.51 | -0.54 | -0.51 | -0.56 | -0.61 | -0.7 | -0.52 | -0.46 | -0.43 | -0.42 | -1.22 | -0.35 | -0.36 | -0.43 | -0.34 | -4.56 | -4.56 |
| EPS Diluted
| -0.4 | -0.5 | -0.51 | -0.54 | -0.51 | -0.56 | -0.61 | -0.7 | -0.52 | -0.46 | -0.43 | -0.42 | -1.22 | -0.35 | -0.36 | -0.43 | -0.34 | -4.56 | -4.56 |
| EBITDA
| -18.506 | -25.559 | -26.465 | -28.239 | -25.609 | -24.32 | -27.598 | -24.048 | -20.455 | -17.026 | -14.969 | -16.831 | -12.634 | -12.294 | -10.424 | -12.485 | -10.222 | -11.093 | -11.093 |
| EBITDA Ratio
| -0.317 | -0.479 | -0.594 | -0.648 | -0.73 | -0.735 | -1.131 | -1.011 | -1.005 | -1.02 | -1.054 | -1.66 | -1.458 | -1.45 | -1.449 | -3.876 | -4.851 | -9.287 | -9.287 |